Folliculotropic mycosis fungoides (FMF) is a variant of (MF) noted in the World Health Organization — European Research and Treatment Cancer (WHO/EORTC) update 2018. FMF characterized as subtype with worse prognosis than classic MF. The situation changed recently when authorities proposed dividing into two prognostically different subtypes: indolent aggressive. Indolent allows 92% patients to s...